
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer metabolism: looking forward
Inmaculada Martínez‐Reyes, Navdeep S. Chandel
Nature reviews. Cancer (2021) Vol. 21, Iss. 10, pp. 669-680
Closed Access | Times Cited: 1207
Inmaculada Martínez‐Reyes, Navdeep S. Chandel
Nature reviews. Cancer (2021) Vol. 21, Iss. 10, pp. 669-680
Closed Access | Times Cited: 1207
Showing 1-25 of 1207 citing articles:
The sirtuin family in health and disease
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 398
Qi‐Jun Wu, Tie‐Ning Zhang, Huanhuan Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 398
The Hippo signalling pathway and its implications in human health and diseases
Minyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 310
Minyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 310
Metabolic programming and immune suppression in the tumor microenvironment
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 249
Emily N. Arner, Jeffrey C. Rathmell
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 421-433
Open Access | Times Cited: 249
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Richard Cunningham, Carsten Gram Hansen
Clinical Science (2022) Vol. 136, Iss. 3, pp. 197-222
Open Access | Times Cited: 205
Richard Cunningham, Carsten Gram Hansen
Clinical Science (2022) Vol. 136, Iss. 3, pp. 197-222
Open Access | Times Cited: 205
Molecular mechanisms of tumor resistance to radiotherapy
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 182
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 182
Designing bioresponsive nanomaterials for intracellular self-assembly
Sarah Chagri, David Y. W. Ng, Tanja Weil
Nature Reviews Chemistry (2022) Vol. 6, Iss. 5, pp. 320-338
Open Access | Times Cited: 161
Sarah Chagri, David Y. W. Ng, Tanja Weil
Nature Reviews Chemistry (2022) Vol. 6, Iss. 5, pp. 320-338
Open Access | Times Cited: 161
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 147
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 147
Molecular basis for redox control by the human cystine/glutamate antiporter system xc−
Joanne L. Parker, Justin C. Deme, Dimitrios Kolokouris, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 146
Joanne L. Parker, Justin C. Deme, Dimitrios Kolokouris, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 146
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 141
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 141
Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 140
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 140
Stimuli-responsive ferroptosis for cancer therapy
Nayeon Kang, Subin Son, Sunhong Min, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 12, pp. 3955-3972
Closed Access | Times Cited: 120
Nayeon Kang, Subin Son, Sunhong Min, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 12, pp. 3955-3972
Closed Access | Times Cited: 120
A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors
Lingxiao Zhang, Jing Zhao, Xi Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Closed Access | Times Cited: 117
Lingxiao Zhang, Jing Zhao, Xi Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Closed Access | Times Cited: 117
RNA modifications in physiology and disease: towards clinical applications
Sylvain Delaunay, Mark Helm, Michaela Frye
Nature Reviews Genetics (2023) Vol. 25, Iss. 2, pp. 104-122
Open Access | Times Cited: 117
Sylvain Delaunay, Mark Helm, Michaela Frye
Nature Reviews Genetics (2023) Vol. 25, Iss. 2, pp. 104-122
Open Access | Times Cited: 117
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 116
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 116
Moonlighting functions of metabolic enzymes and metabolites in cancer
Chaoyun Pan, Bo Li, M. Celeste Simon
Molecular Cell (2021) Vol. 81, Iss. 18, pp. 3760-3774
Open Access | Times Cited: 109
Chaoyun Pan, Bo Li, M. Celeste Simon
Molecular Cell (2021) Vol. 81, Iss. 18, pp. 3760-3774
Open Access | Times Cited: 109
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Dengshuai Wei, Yong Sun, Hu Zhu, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23223-23261
Closed Access | Times Cited: 108
Dengshuai Wei, Yong Sun, Hu Zhu, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23223-23261
Closed Access | Times Cited: 108
Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 99
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 99
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 93
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 93
Bioinspired Electron Polarization of Nanozymes with a Human Self‐Generated Electric Field for Cancer Catalytic Therapy
Shuncheng Yao, Xinyang Zhao, Xueyu Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 15
Closed Access | Times Cited: 92
Shuncheng Yao, Xinyang Zhao, Xueyu Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 15
Closed Access | Times Cited: 92
Molecular Characterization of Exosomes for Subtype-Based Diagnosis of Breast Cancer
Ya Cao, Xiaomeng Yu, Tianyu Zeng, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 30, pp. 13475-13486
Closed Access | Times Cited: 88
Ya Cao, Xiaomeng Yu, Tianyu Zeng, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 30, pp. 13475-13486
Closed Access | Times Cited: 88
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications
Longfei Zhu, Xuanyu Zhu, Yanyou Wu
Biomolecules (2022) Vol. 12, Iss. 4, pp. 580-580
Open Access | Times Cited: 86
Longfei Zhu, Xuanyu Zhu, Yanyou Wu
Biomolecules (2022) Vol. 12, Iss. 4, pp. 580-580
Open Access | Times Cited: 86
Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment
Shilin Wang, Guohong Liu, Yirong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 85
Shilin Wang, Guohong Liu, Yirong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 85
TRIM family contribute to tumorigenesis, cancer development, and drug resistance
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 82
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 82